China’s Beijing Balance Medical Technology Co., Ltd (SHA: 688198) has announced that its transcatheter valve system has entered the innovative medical device special review process in China, marking a significant step forward in the advancement of valve replacement therapies.
A New Approach to Postoperative Valve Replacement
The interventional valve system is a groundbreaking transcatheter valve system designed specifically for postoperative patients who have already implanted various types of artificial biological valves. Traditionally, when implanted valves become damaged, these patients face the need for replacement surgeries, which carry high surgical risks. Beijing Balance Medical’s product offers a less invasive alternative by allowing for multiple valve positions to be treated simultaneously through catheter insertion via 7 different pathways, regardless of the valve’s position or the type of damaged biological valve.
Enhanced Treatment Options for Complex Valve Damages
This innovative system provides a significant advancement in the treatment of patients with multiple valve position damages within implanted biological valves. The ability to perform re-intervention treatments for damaged valves at each valve position in a single procedure simplifies the treatment process and reduces the risks associated with multiple surgeries. The system’s versatility and adaptability to various valve positions and types make it a promising development in the field of cardiovascular medicine.-Fineline Info & Tech
